Publications by authors named "Arastehfar A"

Objectives: Worldwide emergence of clonal outbreaks caused by fluconazole-resistant (FLCR) and the recent emergence of echinocandin- and multidrug-resistant (ECR and MDR) Candida parapsilosis isolates pose serious threats to modern clinics. Conducting large-scale epidemiological studies aimed at determining the genetic composition and antifungal resistance rates is necessary to devise antifungal stewardship and infection control strategies at international, national and local levels. Despite being severely hit by outbreaks due to FLCR C.

View Article and Find Full Text PDF

Drug-resistant microbes typically carry mutations in genes involved in critical cellular functions and may therefore be less fit under drug-free conditions than susceptible strains. Candida glabrata is a prevalent opportunistic yeast pathogen with a high rate of fluconazole resistance (FLZR), echinocandin resistance (ECR), and multidrug resistance (MDR) relative to other Candida. However, the fitness of C.

View Article and Find Full Text PDF
Article Synopsis
  • Fungal infections are becoming more common because more people are at risk and climate change is affecting health.
  • There are only a few types of antifungal medicines available, and they have problems like resistance from fungi and side effects that need close monitoring.
  • Scientists are exploring new antifungal options, including inhaled treatments and ways to boost the immune system, to better fight these infections and understand issues like drug resistance.
View Article and Find Full Text PDF

Although rare, trans-kingdom infection features an interesting infection biology concept, in which highly versatile pathogenic attributes allow successful infections in evolutionarily highly divergent species. is a phytopathogenic fungus and occasionally causes human infections. Herein, we report a phaeohyphomycosis case caused by .

View Article and Find Full Text PDF

Unlabelled: Recent epidemiological studies documented an alarming increase in the prevalence of echinocandin-resistant (ECR) blood isolates. ECR isolates are known to arise from a minor subpopulation of a clonal population, termed echinocandin persisters. Although it is believed that isolates with a higher echinocandin persistence (ECP) are more likely to develop ECR, the implication of ECP needs to be better understood.

View Article and Find Full Text PDF

is known to cause severe and persistent outbreaks in clinical settings. Patients infected with multidrug-resistant (MDR Cp) isolates were identified in a large Turkish hospital from 2017-2020. We subsequently identified three additional patients infected with MDR Cp isolates in 2022 from the same hospital and two echinocandin-resistant (ECR) isolates from a single patient in another hospital.

View Article and Find Full Text PDF

is a major fungal pathogen, which is able to lose mitochondria and form small and slow-growing colonies, called "petite." This attenuated growth rate has created controversies and questioned the clinical importance of petiteness. Herein, we have employed multiple omics technologies and mouse models to critically assess the clinical importance of petite phenotype.

View Article and Find Full Text PDF

Unlabelled: Small colony variants (SCVs) are relatively common among some bacterial species and are associated with poor prognosis and recalcitrant infections. Similarly, - a major intracellular fungal pathogen - produces small and slow-growing respiratory-deficient colonies, termed "petite." Despite reports of clinical petite .

View Article and Find Full Text PDF

Candida parapsilosis is a significant cause of candidemia worldwide. Echinocandin-resistant (ECR) and echinocandin-tolerant (ECT) C. parapsilosis isolates have been reported in various countries but are rare.

View Article and Find Full Text PDF
Article Synopsis
  • Candida parapsilosis is a major cause of life-threatening candidaemia, especially in vulnerable populations like premature neonates and organ transplant recipients.
  • Outbreaks of fluconazole-resistant strains have increased since 2018, leading to high mortality rates and challenging infection control measures.
  • The emergence of multidrug-resistant strains highlights the urgent need for better clinical interventions and understanding of this pathogen to enhance treatment options.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used whole-genome sequencing (WGS) and CRISPR-Cas9 technology to investigate the origins of new MDR-Cp isolates and to confirm that the FKS1R658G mutation is responsible for echinocandin resistance.
  • * Treatment in the case study involved fluconazole, which was ineffective, but the patient responded well to liposomal amphotericin B (LAMB); the results highlight the need for ongoing surveillance and new strategies for
View Article and Find Full Text PDF

Candida glabrata is a major fungal pathogen notable for causing recalcitrant infections, rapid emergence of drug-resistant strains, and its ability to survive and proliferate within macrophages. Resembling bacterial persisters, a subset of genetically drug-susceptible C. glabrata cells can survive lethal exposure to the fungicidal echinocandin drugs.

View Article and Find Full Text PDF

Patients presenting with severe COVID-19 are predisposed to acquire secondary fungal infections such as COVID-19-associated candidemia (CAC), which are associated with poor clinical outcomes despite antifungal treatment. The extreme burden imposed on clinical facilities during the COVID-19 pandemic has provided a permissive environment for the emergence of clonal outbreaks of multiple species, including and . Here we report the largest clonal CAC outbreak to date caused by fluconazole resistant (FLZR) and echinocandin tolerant (ECT) .

View Article and Find Full Text PDF

Background: Galactomannan Enzyme Immunoassay (GM-EIA) is proved to be a cornerstone in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA), its use is limited in middle and low-income countries, where the application of simple and rapid test, including Galactomannan Lateral Flow Assay (GM-LFA), is highly appreciated. Despite such merits, limited studies directly compared GM-LFA with GM-EIA. Herein we compared the diagnostic features of GM-LFA, GM-EIA and bronchoalveolar lavage (BAL) culture for CAPA diagnosis in Iran, a developing country.

View Article and Find Full Text PDF

Fluconazole-resistant (FLZR-CP) outbreaks are a growing public health concern and have been reported in numerous countries. Patients infected with FLZR-CP isolates show fluconazole therapeutic failure and have a significantly increased mortality rate. Because fluconazole is the most widely used antifungal agent in most regions with outbreaks, it is paramount to restore its antifungal activity.

View Article and Find Full Text PDF
Article Synopsis
  • The landscape of invasive infections is changing, with rising cases of infections caused by non-albicans species, while advancements in antifungal drugs are promising, particularly with new repurposed options and mechanisms of action.
  • Current antifungal treatments for invasive candidiasis still face challenges, especially in terms of oral administration and penetration into the central nervous system.
  • New investigational antifungal agents, such as Ibrexafungerp and Rezafungin, show potential for better treatment options, but there is a pressing need for more clinical research, particularly for handling resistant strains of infections.*
View Article and Find Full Text PDF

Background: We evaluated the epidemiology of candidemia among coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs).

Methods: We conducted a retrospective multicenter study in Turkey between April and December 2020.

Results: Twenty-eight of 148 enrolled patients developed candidemia, yielding an incidence of 19% and incidence rate of 14/1000 patient-days.

View Article and Find Full Text PDF

is the second most common cause of candidemia in some geographical areas and in children in particular. Yet, the proportion among children varies, for example, from 10.4% in Denmark to 24.

View Article and Find Full Text PDF

Knowledge about the clinical characteristics and prognostic factors of Talaromyces marneffei infection in children is limited, especially in HIV-positive children. We performed a retrospective study of all HIV-positive pediatric inpatients with T. marneffei infection in a tertiary hospital in Southern China between 2014 and 2019 and analyzed the related risk factors of poor prognosis using logistic regression.

View Article and Find Full Text PDF

Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS-CoV2, which might favour secondary infections. In this Review, we analysed 80 published and unpublished cases of COVID-19-associated mucormycosis.

View Article and Find Full Text PDF

is the second leading cause of candidemia in many countries and is one of the most concerning yeast species of nosocomial importance due to its increasing rate of antifungal drug resistance and emerging multidrug-resistant isolates. Application of multilocus sequence typing (MLST) to clinical isolates revealed an association of certain sequence types (STs) with drug resistance and mortality. The current MLST scheme is based on single nucleotide polymorphisms (SNPs) at six loci and is therefore relatively laborious and costly.

View Article and Find Full Text PDF
Article Synopsis
  • * The research identifies significant risk factors such as the use of central venous catheters and broad-spectrum antibiotics, finding that most patients had mixed infections, and that azoles demonstrate poor efficacy compared to amphotericin B (AMB).
  • * The findings suggest a critical need for clinicians to consider AMB formulations over azoles for treating infections caused by this pathogen, highlighting the potential for further research on alternative treatments.
View Article and Find Full Text PDF

The epidemiology of invasive fungal infections is changing, with new populations at risk and the emergence of resistance caused by the selective pressure from increased usage of antifungal agents in prophylaxis, empiric therapy, and agriculture. Limited antifungal therapeutic options are further challenged by drug-drug interactions, toxicity, and constraints in administration routes. Despite the need for more antifungal drug options, no new classes of antifungal drugs have become available over the last 2 decades, and only one single new agent from a known antifungal class has been approved in the last decade.

View Article and Find Full Text PDF

Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among mechanically ventilated patients.

View Article and Find Full Text PDF

Species of and related genera are widely used in biotechnology and, hence, many species have their genome sequenced. Importantly, yeasts of the genus have been increasingly identified as a cause of life-threatening invasive trichosporonosis (IT) in humans and are associated with an exceptionally high mortality rate. spp.

View Article and Find Full Text PDF